Scholars Central

Conference abstractPublished 15 Oct 2013

Inhibitors of fatty acid amide hydrolase (FAAH): SAR and results in pre-clinical pain models

Authors: J. Guy Breitenbucher

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Pharmacologically active preparations of Cannabis sativa have been recognized since ancient times as having potentially useful therapeutic effects, including analgesia. With the discovery and cloning of the cannabinoid receptors CB1 and CB2, and the subsequent discovery of anandamide, the first endogenous substance with agonist activity at both receptors, a rationale for the analgesic effects of cannabis was developed. Anandamide has a short half-life, due to rapid hydrolysis by the enzyme fatty acid amide hydrolase (FAAH) resulting in low resting concentrations in the CNS. FAAH knockout mice have been described and have elevated resting brain concentrations of anandamide, and manifest a phenotypic analgesia in several commonly used models of pain. Furthermore, known inhibitors of FAAH show amelioration of pain behaviors in rats. The present account describes the discovery of a novel classes of FAAH inhibitors and describes our work to characterize the SAR and pharmacology of these FAAH inhibitors.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Medicinal Chemistry.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalMedicinal Chemistry
  • SubjectChemistry
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “J. Guy Breitenbucher”